Abstract | The glomerular basement membrane (GBM) is the central, non-cellular layer of the glomerular filtration barrier that is situated between the two cellular components-fenestrated endothelial cells and interdigitated podocyte foot processes. The GBM is composed primarily of four types of extracellular matrix macromolecule-laminin-521, type IV collagen α3α4α5, the heparan sulphate proteoglycan agrin, and nidogen-which produce an interwoven meshwork thought to impart both size-selective and charge-selective properties. Although the composition and biochemical nature of the GBM have been known for a long time, the functional importance of the GBM versus that of podocytes and endothelial cells for establishing the glomerular filtration barrier to albumin is still debated. Together with findings from genetic studies in mice, the discoveries of four human mutations affecting GBM components in two inherited kidney disorders, Alport syndrome and Pierson syndrome, support essential roles for the GBM in glomerular permselectivity. Here, we explain in detail the proposed mechanisms whereby the GBM can serve as the major albumin barrier and discuss possible approaches to circumvent GBM defects associated with loss of permselectivity.
Introduction
The glomerular basement membrane (GBM) is a thin (250-400 nm) meshwork of extracellular matrix proteins that is an integral part of the glomerular filtration barrier. Most of the GBM is situated between two cellular layers-glomerular endothelial cells and podocytes-in the peripheral capillary wall ( Figure 1) ; the remaining GBM segments lie between mesangial cells and podocytes at the bases of the capillary loops. 1 The GBM both provides structural support for the glomerular capillaries and harbours ligands for receptors on the surface of the adjacent endothelial cells, podocytes, and mesangial cells. 2, 3 Importantly, the GBM also contributes to glomerular permselectivity: as the second layer of the capillary wall that is encountered by filtrate, it is thought to restrict the passage of plasma proteins across the glomerular filtration barrier. In support of this idea, of the nine major proteins found in the GBM, mutations in genes encoding four of them are known to cause human kidney diseases 4, 5 (Alport syndrome and Pierson syndrome) that involve proteinuria-the leakage of valuable plasma protein, mostly albumin, into the urine.
Although mutations affecting GBM components are important causes of kidney disease, environmental changes that affect the glomerulus can also lead to alterations in the composition and structure of the GBM. Diabetic nephropathy is one example in which the GBM is adversely affected by the microenvironment. 6 Diabetic nephropathy is becoming more and more prevalent as a result of the worldwide increases in obesity and type 2 diabetes mellitus. About 40% of individuals with diabetes develop diabetic nephropathy, which then leads to more patients with chronic kidney disease in need of dialysis. 7 Although it is clear that proteinuria and renal failure originate from both genetic and environmental factors, in all but a few cases it is very difficult to clearly define a genetic component. Much research has focused on the cellular components of the glomerulus-the podocytes, endothelial cells, and mesangial cells-because they can actively respond to genetic and environmental changes by producing gene products and cell-signalling molecules. However, changes in these cells can also give rise to changes in the GBM, which can secondarily affect the properties and behaviour of the neighbouring cells through matrix-to-cell (outside-in) signalling events. Similarly, primary changes in the GBM may exert functionally important effects on the neighbouring podocytes, endothelial cells, and mesangial cells, thereby affecting glomerular filtration.
Whether and how the GBM contributes to the establishment and function of the glomerular filtration barrier to protein have been debated for several decades. 8 More recent findings gleaned from genetic and physiological studies have provided a better view of how the GBM could function as a barrier. Further understanding the mechanisms in various disease models could help in the design of therapeutics that could prevent or reverse proteinuria by impacting GBM structure and function.
This Review focuses mainly on the mechanisms by which the GBM functions to establish and maintain the glomerular filtration barrier. From results from genetic and biochemical studies in mice and humans, it is evident that the GBM is crucial to prevent the leakage of plasma proteins into the urine. We emphasize the critical role of the GBM as a permselective barrier that can be altered in different ways by genetic defects that cause kidney disease.
GBM components' role in permselectivity
In order to understand how the GBM might contribute to permselectivity, it is important to define its composition and to understand the properties of its major components. Like all basement membranes, the GBM is composed of laminin, type IV collagen, heparan sulphate proteoglycan, and nidogen. 9 Components of the GBM are synthesized by both podocytes and endothelial cells, 10 and during glomerulogenesis the separate podocyte-derived and endothelium-derived basement membranes fuse to form the immature GBM. This feature is responsible at least in part for the GBM being thicker than most other basement membranes, as both cell layers synthesize extracellular matrix components and secrete them into the extracellular space between them. Furthermore, one can infer that changes in either podocytes or endothelial cells can result in altered GBM composition-and vice versapossibly affecting the function of the glomerular filtration barrier. In this context, podocytes, endothelial cells, and the GBM can be viewed as being inter connected; this idea is evident not only through the obvious direct physical contacts within cell layers and between cells and the GBM, but also across the GBM through both cellmatrix-cell connections and cell-cell communication and/or signalling via diffusible factors. One excellent example of the latter is the vascular endothelial growth factor (VEGF) signalling axis, in which podocyte-derived VEGF is crucial for endothelial cell homeostasis. 11 Historically, the GBM was considered by some researchers to be a 'crude prefilter' , and slit diaphragms between podocyte foot processes were thought to be responsible for the bulk of glomerular permselectivity. 12 However, as proposed by Farquhar and Palade, functional and physiological analyses of the glomerular filtration barrier using various tracers revealed the importance of the GBM as a size-selective and charge-selective filtration barrier. [13] [14] [15] When neutral tracers of various sizes were intravenously injected, molecules larger than albumin were found to be restricted to the inside of the glomerular capillary loops and were impaired from traversing the GBM. Likewise, when neutral, anionic and cationic tracers were infused, negatively charged molecules had the most difficulty in crossing the GBM. 15 From these studies, the function and necessity of the components of the GBM were inferred based on their biochemical properties. However, the most direct evidence as to whether each component of the GBM is essential for establishing the filtration barrier was provided by mouse genetic studies and the discovery of human mutations that cause defects in glomerular permselectivity.
Laminins
Laminins are large heterotrimeric glycoproteins composed of three different homologous chains: α, β, and γ. In humans, five α chains, four β chains, and three γ chains Key points ■ The glomerular basement membrane (GBM) is the extracellular matrix component of the glomerular filtration barrier; it is flanked by the podocyte and glomerular endothelial cell layers ■ The major GBM components are laminin-521, type IV collagen α3α4α5, nidogen, and the heparan sulphate proteoglycan agrin ■ Mutations in COL4 genes that result in absence of the type IV collagen α3α4α5 network cause Alport syndrome, a hereditary nephritis accompanied by hearing defects ■ Mutations in laminin β2 (LAMB2) cause Pierson syndrome, a congenital nephrotic syndrome with associated eye and neurologic abnormalities ■ Studies using mouse models of Pierson and Alport syndromes have shown that the defective GBM is more permeable to macromolecules than is the normal GBM, suggesting that it has a role in permselectivity assemble to form at least fifteen distinct laminin trimers; 16 depending on the α-β-γ chain composition, these laminin trimers resemble cruciform, Y-shaped, or rod-shaped structures. Each chain has a laminin coiled-coil domain, 17 and interactions between three coiled-coil domains and limited interchain covalent bonding contribute to the formation of the long arm of all laminin trimers. 18 The remaining segment of each chain is called a short arm. The short arms of the cruciform trimers contain a laminin N-terminal (LN) domain, which has an essential role in the polymerization of trimers to form a network. 19, 20 Laminin α chains are unique because they also contain a C-terminal laminin globular (LG) domain, composed of five tandem sub-domains, which is situated distal to the long arm. 21 LG domains link laminin trimers in basement membranes to neighbouring cells by serving as ligands for two major cellular receptors, integrins and dystroglycan. 22, 23 Urinary space
GBM components
Laminin-521 Type IV collagen α3α4α5 Integrins are transmembrane αβ heterodimers that are crucial in many different contexts for cell-to-extracellular matrix signalling and vice versa, as well as for direct cellcell signalling. 24 Integrin α3β1 is the predominant integrin normally present on the basal surface of podocytes, and deletion of α3β1 results in severe kidney glomerular defects during development. 25 Integrin α3β1 binds to laminin α5β1γ1 (LM-511) and α5β2γ1 (LM-521) through the α5 chain's LG domain. 26 The binding of α5LG to integrin α3β1 is essential for the formation of the typical glomerular capillary loop structure, probably because the mesangial cells that organize the capillaries also express integrin α3β1. 27 Dystroglycan also binds to the LG domain of α chains, 28 but the deletion of dystroglycan from most kidney cells does not result in a kidney defect, suggesting that integrin α3β1 has a more important role than dystroglycan in extracellular matrix-to-cell adhesion and signalling in the kidney. 29 Secretory signal peptides are located at the N-terminus of each laminin chain, which targets them to the endoplasmic reticulum as they are synthesized. Laminin trimers assemble and become glycosylated in the endoplasmic reticulum and are processed further in the Golgi apparatus. 30 After secretion into the extracellular space, laminin trimers self-polymerize to form a laminin network by interactions between LN domains. 20 This polymerization step is a reversible and calcium-dependent process that requires a critical concentration of laminin trimers to form an initiating complex. 19 This initial step is facilitated by the binding of laminin trimers to laminin receptors via their α-chain LG domains, 31 which increases the local concentration of laminin trimers and helps trigger laminin polymerization. Interactions that involve the other basement membrane molecules (type IV collagen, nidogen, and sulphated proteoglycan) then enable the assembly of a basement membrane. Interestingly, mice that lack α1 and α2 type IV collagen do assemble basement membranes during early embryonic development, but these basement membranes are unstable, leading to embryonic death by embryonic day 11. 32 However, the deletion of laminin γ1 (a component of all early laminins) in mice caused much earlier lethality (by embryonic day 5.5) and the total absence of basement membranes. 33 These data indicate that laminin is indispensible for the initial formation of basement membranes, whereas type IV collagen is not. In addition, the quantity of efficiently polymerizing laminin in the GBM is important for restricting the passage of plasma macromolecules across the glomerular filter, as will be discussed.
Type IV collagen
Type IV collagen is the most abundant protein found in basement membranes, comprising about 50% of total protein mass. Six genetically distinct collagen IV α chains exist-α1 through α6-and these chains assemble to form three different heterotrimers referred to as protomers: α1α1α2, α3α4α5 and α5α5α6. Like all collagen chains, the collagen IV chains contain Gly-X-Y amino acid triplet repeats. However, unlike fibril-forming collagens of bone and cartilage, the Gly-X-Y repeat region of collagen IV displays multiple interruptions, imparting flexibility to the collagen IV protomer and to the network that it forms in basement membranes.
Each collagen IV α chain has three domains: the N-terminal 7S domain, the collagenous domain containing the interrupted Gly-X-Y repeats (with X and Y usually being Lys or Pro), and the noncollagenous domain (NC1) at the C-terminus. Collagen IV protomers are assembled inside the endoplasmic reticulum and secreted into the extracellular space. There, they selfpolymerize into a 'chicken-wire-like' network through hexameric and dodecameric interactions involving the NC1 and 7S domains, respectively, and become heavily cross-linked through disulphide bonds, sulfilimine bonds, and lysyl-oxidase-mediated crosslinks. 34, 35 In the GBM, a transition in the composition of collagen IV chains occurs, from α1α1α2 in the immature GBM to α3α4α5 in the mature GBM. 36 This transition occurs coincidentally with the transition of laminin chains in the GBM. The molecular mechanisms controlling the switch of collagen IV and laminin chains in the GBM are unknown. However, the collagen IV transition might be required to accommodate the increased blood pressure in adults, since α3α4α5 type IV collagen produces a more heavily cross-linked and more protease-resistant network compared to the α1α1α2 type IV collagen network. 37 The importance of the α3α4α5 type IV collagen network in the glomerular capillary wall is illustrated by the fact that its absence causes Alport syndrome, 35 a glomerular disease that will be discussed in detail.
Nidogen
The nidogens, also known as entactins, are two homologous glycoproteins containing three globular-like domains with two rod-like domains separating the globular-like domains. 38 Nidogen-1 and nidogen-2, both found in the GBM, are encoded by two different genes. Nidogen-1 binds to both laminin γ1 and type IV collagen, a finding that led to the hypothesis that nidogen acts as a bridge linking the separate laminin and type IV collagen networks in basement membranes. 39 Deletion of either nidogen gene in mice does not cause any significant abnormalities, probably because of overlapping expression and redundant functions. [40] [41] [42] [43] Nidogen-1 and nidogen-2 double-knockout mice, however, exhibit perinatal lethality due to lung and heart malformations, but many basement membranes form normally without nidogen, despite the ability of nidogen to link laminin and type IV collagen networks. 44 The data suggest that nidogens provide extra stability to basement membranes under situations of unusual stress, but that they are not required for the initial formation of basement membranes. As no definitive evidence exists to indicate that either nidogen alone contributes to the properties of the GBM as a barrier, they will not be discussed in that context.
Heparan sulphate proteoglycan
Heparan sulphate proteoglycans have sulphated glycosaminoglycan side chains linked to a protein core. Although perlecan seems to be the prominent heparan sulphate proteoglycan in most basement membranes 39 and in the mesangial matrix, agrin is the major heparan sulphate proteoglycan in the GBM. 45 The sulphated glycosaminoglycan side chains of agrin give it a highly negative charge that is reflected by anionic sites within the GBM that can be detected with cationic probes such as polyethyleneimine and cationized ferritin. 46, 47 The N-terminal domain of agrin binds avidly to the LM-521 long arm, and its C-terminus bears domains that can bind to cell-surface receptors such as dystroglycan and integrins. 48 These properties of agrin suggest that it could have importance in mediating charge selectivity within the glomerular filtration barrier and in linking the GBM to the adjacent cells. In addition, heparan sulphate side chains are important for binding and sequestering growth factors in some contexts; one such growth factor secreted by podocytes that must cross the GBM and could benefit from the presence of such side chains is VEGF. 11, 49 However, podocyte-specific mutation of the gene encoding agrin in mice did not lead to any structural or functional defects in the glomerulus, although it did greatly reduce the density of negatively charged sites within the GBM and cause a dramatic reduction in the level of full-length agrin protein in the GBM. These results suggest that agrin and the negative charge of the GBM do not play critical roles in the filtration barrier. 46 Furthermore, the deletion of both agrin and the heparan sulphate side chains on perlecan also had little if any effect on permselectivity, 50 despite the fact that a previous report had revealed a potential role for perlecan in filtration in the context of protein overload. 51 No critical role for agrin in the GBM, either as a matrix protein or as an anionic macromolecule, has been proven, so agrin will not be discussed further in relation to the glomerular filtration barrier.
Diseases associated with GBM malfunction
As mentioned earlier, two relatively well understood genetic kidney diseases are known to target components of the GBM: Pierson syndrome and Alport syndrome. Although these two diseases both involve primary defects in GBM components, they have very different clinical presentations; these differences provide some clues as to the specific roles of laminin and type IV collagen networks in influencing glomerular permselectivity.
Pierson syndrome
In the early 1960s, Pierson et al. described two infants from one family with microcoria and congenital nephrotic syndrome. 52 Both infants presented with severe congenital nephrotic syndrome and early-onset endstage renal disease (ESRD), and died 2 weeks after birth. The iris dilator muscles in their eyes showed aplasia and/ or atrophy and an abnormal lens. In 2004, Zenker and colleagues reported a case of congenital nephrotic syndrome with clinical features that included microcoria and mesangial sclerosis, similar to the features described by Pierson, and the condition was termed Pierson syndrome. 53 Homozygosity mapping of five affected families identified autosomal recessive mutations in LAMB2, the gene encoding laminin β2. 53 Follow-up of Pierson et al.'s original cases via screening of healthy living family members revealed two different mutations in LAMB2, suggesting that the original cases were compound hetero zygotes. 54 These findings highlight the critical role of laminin β2 for normal kidney function, especially glomerular filtration barrier function.
The recognition of Pierson syndrome as a specific disease entity by the discovery of LAMB2 mutations spurred more reports of cases of Pierson syndrome. 5, 55 With increasing numbers of reports, it has become clear that the onset and severity of Pierson syndrome varies greatly between patients in terms of progression of nephrotic syndrome and extra-renal manifestations, such as muscular hypotonia and neurodevelopmental deficits, resulting in a 'spectrum' of Pierson syndrome with genotype-phenotype correlations. 56, 57 Truncating mutations, which are dispersed throughout the LAMB2 gene, are generally associated with more severe phenotypes than are missense mutations, as truncated proteins often lack the coiled-coil domain that is critical for the assembly of LM-521 trimers. 5 By contrast, pathogenic missense mutations in LAMB2 are found primarily in the LN domain, probably resulting in defects in laminin polymerization and/or secretion. 5, 58, 59 Thus, for patients in the Pierson syndrome spectrum, the mutations in LAMB2 result in a total absence or reduced level of LM-521 in the GBM or in the formation and secretion of dysfunctional LM-521 trimers.
The straightforward interpretation of the mechanism of proteinuria in Pierson syndrome is that the lack of LM-521 causes a defect in the ability of the GBM to attenuate the passage of albumin from the plasma to the Bowman space. Given the evidence for the involvement of both podocytes and endothelial cells in regulating permselectivity, however, an alternative hypothesis is that defects in the GBM prevent proper cell-matrix interactions and signalling to cells, resulting in cellular defects that lead to proteinuria. The rigorous investigation of these hypotheses requires experiments that cannot be performed in humans. Fortunately, mice with a null mutation in Lamb2 have provided an excellent model in which to study Pierson syndrome, as they recapitulate the congenital nephrotic syndrome and die at about 3 weeks of age with severe proteinuria and neuromuscular defects. 60, 61 They also show accumulation of ectopic laminin chains in the GBM, including α1, α2, α3, β1, β3, and γ2 ( Figure 2) . 62 This deposition of ectopic laminins into the GBM may be a compensatory response to the loss of laminin β2 and thus LM-521, but it is not sufficient to establish a fully functional glomerular filtration barrier. 62 Interestingly, the glomerular ultrastructure of proteinuric 1-week-old Lamb2-null mice reveals intact podocyte foot processes ( Figure 2 ) and slit diaphragms, suggesting a role for the GBM as an independent and indispensible filtration barrier to plasma proteins. 62 Importantly, these data show that proper GBM laminin composition is not required for what appears to be the elaboration by podocytes of proper foot processes with slit diaphragms in functioning glomeruli, at least in early stages of development. In mice, and presumably also in humans, foot process effacement follows later (shown at 2 weeks of age for mice in Figure 2 ) and may even be caused by the increasing proteinuria that eventually reaches nephrotic range.
In further support of a direct role for the GBM in mediating permselectivity, the use of ferritin as an electron-dense tracer to monitor the permeability of the GBM to plasma macromolecules showed that the lack of LM-521 in Lamb2-null mice was associated with an increase in GBM permeability relative to the permeability of the GBM in control littermates; this increase was apparent before widespread foot process effacement and loss of slit pores. 62 Similar to previously reported results using albumin and ferritin tracing in situ, 13, 14, 63 no accumulation of ferritin occurred below the slit diaphragms, suggesting that the slit diaphragms do not act as restrictive pores in the physiological state. 62 These results are, however, in conflict with structural studies of the slit diaphragm that show the pore sizes to be of similar size to or smaller than the size of albumin. 64 Alport syndrome Alport syndrome is a hereditary glomerular, auditory, and ocular disease caused by mutations in the COL4A3, COL4A4, or COL4A5 genes that encode the type IV collagen α3, α4, and α5 chains, respectively. 4, 65 Because the collagen IV network of the GBM consists primarily of cross-linked α3α4α5(IV) protomers made by podocytes, 66 the lack of any one of the three chains (for example, as a result of a null mutation) prevents the protomer from forming. Moreover, missense mutations-particularly those that cause glycine substitutions in the collagenous domain-can lead to defects in protomer structure and in the collagen IV network and therefore also cause Alport syndrome.
In the absence of the α3α4α5(IV) network, a compensatory increase occurs in the abundance of the α1α1α2(IV) network, which is normally a minor component in the subendothelial aspect of the mature human GBM and is barely detectable in the normal mouse GBM. This compensation enables the GBM to form and function properly for several years in humans, but eventually haematuria occurs that accompanies a characteristic splitting and thickening of the GBM, as also occurs in Alport mice (Figure 3 ). These changes are followed by the onset of protein uria that increases and signifies declining glomerular filtration rate (GFR). The majority of patients, most of whom are males carrying X-linked COL4A5 mutations, eventually require renal replacement therapy. By contrast, only a minority of female carriers of X-linked Alport syndrome progress to ESRD. The rarer autosomal forms of Alport syndrome affect males and females equally.
The fact that proteinuria appears late in the disease process suggests that collagen IV is not as important as laminin for maintaining glomerular permselectivity. However, studies of a mouse model of Alport syndrome show that the GBM in mice with Alport syndrome is more permeable to ferritin than is the GBM from normal mice, indicating that collagen IV is important for the filtration barrier. 67 The areas of increased permeability also showed ectopic deposition of laminin α1 plus increased levels of laminin α5, 67 suggesting the possibility that secondary changes in the laminin network, together with the defect in the collagen IV network, might be responsible for the increased permeability of the GBM that occurs in Alport syndrome. The fact that proteinuria appears late in the course of the disease might be because any early increase in the level of filtered albumin is masked by increased albumin uptake by proximal tubular cells.
Treatment of Alport syndrome in mice and humans with angiotensin-converting-enzyme inhibitors has been shown to slow the onset of proteinuria and the decline in GFR. 68, 69 A reduction in blood pressure should put less stress on the defective, imperfectly cross-linked GBM, on the adjacent podocyte, and on the entire glomerulus, which exhibits increased deformability. 70 Moreover, biomechanical strain has been proposed to change gene expression in ways that exacerbate glomerular disease in Alport syndrome. 71 
Conclusions
So what are the mechanisms whereby laminin and collagen IV might be directly involved in glomerular perm selectivity? According to concepts proffered by Smithies, 72 the GBM behaves like a concentrated gel that has size-selective properties and into which macro molecules such as albumin permeate primarily by diffusion. As the major components of the GBM, the laminin-521 and collagen IV networks, in concert with the other GBM components, likely impart the GBM with its characteristic porosity. By analogy to the polyacrylamide gel, which also has size-selective properties, it is easy to understand the following: firstly, how reducing laminin or type IV collagen concentration might be similar to reducing the percentage of acrylamide; and secondly, how changing laminin or type IV collagen isoforms might be similar to changing the ratio of acrylamide to bis-acrylamide. The result of either of these scenarios could be increased permeabi lity via increased pore sizes. Consistent with this idea, our hypothesis that Lamb2-null mice develop nephrotic syndrome owing to a paucity of laminin in the GBM, and therefore a defective laminin network in the GBM, is supported by our data from transgenic mice with podocyte-specific overexpression of laminin β1 and thus LM-511. On the Lamb2-null background, the forced secretion of high levels of LM-511 from podocytes into the GBM prevented the nephrotic syndrome that would have otherwise developed, and the mice lived a long life. 73 These data also suggest that in the GBM the quantity of laminin is important, as LM-511 could efficiently substitute for LM-521 if expressed at a high enough level. An exciting conclusion from this study is that upregulation of the unaffected LAMB1 gene in the podocytes of patients with Pierson syndrome may be an effective therapy. Moreover, we have shown that secretion of a secretion-defective mutant laminin β2 (C321R-LAMB2) could be improved in vitro by treatment with a chemical chaperone, 74 which promotes proper protein folding. This result suggests that such a chemical chaperone could be a possible drug therapy for patients with Pierson syndrome who have missense LAMB2 mutations that impair protein folding and/or secretion. Additional studies in mice suggest that the three C-terminal segments of the LG domain of laminin α5 are critical for a proper filtration barrier, 75 for reasons that are not yet understood. Future studies concentrating on the possible mechanisms for this finding could reveal novel approaches for tightening the glomerular barrier to albumin and reducing albuminuria.
Given the well-demonstrated importance of multiple podocyte proteins for proper foot process architecture and for permselectivity (as is discussed in detail elsewhere 76 ), it is important to determine how this role can be reconciled with the concept that the GBM is a major contributor to the physical filtration barrier. Based on cell biological concepts put forth previously, 77 we propose that the reason that the podocyte cytoskeleton and slit diaphragms are so critical for normal filtration is because they are connected (either directly or indirectly) to cell surface receptors-primarily integrins-that link to the GBM via LM-521. In turn, these receptors are critical for organizing the arrangement of the GBM's components and can thereby regulate its architecture, its porosity, and thus its permselectivity.
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